Background Stereotactic arrhythmia radioablation (STAR) is a novel, non-invasive treatment for therapy-refractory ventricular tachycardia (VT). In STAR, a high dose of radiation is used to ...

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a malignant inherited cardiac condition, with a higher lethality than long QT syndrome and hypertrophic cardiomyopathy. The annual ...

The large sample size enabled a quantitative comparison of the clinical outcomes among the premature ventricular complex/ventricular tachycardia categories following catheter ablation. The limitations ...

Introduction Polymorphic ventricular tachycardia (VT) is defined as a rapid rhythm with continuously changing ventricular activation. 1 In the absence of QT interval prolongation, its evaluation is a ...

Bidirectional ventricular tachycardia (VT) during a treadmill test led to the diagnosis of catecholaminergic polymorphic ventricular tachycardia (CPVT). Genetic testing revealed a pathogenic variant ...

View this table: Table 1 Causes of wide complex tachycardias (WCTs) in patients without structural heart disease Broad categories of WCTs include ventricular tachycardia (VT), SVT with abnormal ...

Polymorphic ventricular tachycardia (VT) is a malignant ventricular tachyarrhythmia with changing QRS pattern that will either terminate spontaneously (causing syncope if it lasts more than a few ...

This article describes IV lidocaine antiarrhythmic properties; i.e., its use in treating arrhythmias, including ventricular tachycardia.

Ventricular tachycardia causes your heart to beat too fast. Learn more about the symptoms, causes, risk factors, diagnosis, treatment, and prevention.

Catheter ablation of premature ventricular contractions (PVCs) that trigger polymorphic ventricular tachycardia (PVT) or ventricular fibrillation has been reported as a novel therapy to reduce the ...

The findings, they say, question such routine CAD/ischemia testing in patients like those studied, who had episodes of monomorphic ventricular tachycardia (VT) storm but not an acute coronary ...

ARMGO Pharma, Inc. announced the enrollment of the first patient in a Phase 2 proof of concept clinical trial using its Rycal ARM210, for the treatment of Catecholaminergic Polymorphic Ventricular ...